Literature DB >> 20483808

Review paper: basic concepts to novel therapies: a review of the diabetic foot.

Aonghus O'Loughlin1, Caroline McIntosh, Sean F Dinneen, Timothy O'Brien.   

Abstract

Diabetes mellitus is a global epidemic. Peripheral neuropathy and peripheral vascular disease are complications of diabetes mellitus and the primary causative factors for foot ulceration. Foot ulceration is the leading cause of hospitalization in people with diabetes mellitus. The burden of foot ulceration on health care systems and individual patients is immense. Despite conventional treatment, there persists a high incidence of amputation. A multidisciplinary approach is required to prevent ulcers. This review describes the etiology and risk factors for diabetic foot ulceration and a system for evaluating the diabetic foot. The assessment of neuropathy and the grading of foot ulcers are critically examined. This is important to allow for standardization in clinical trials. The management of diabetic foot syndrome is reviewed. The treatments to ensure vascular supply to the lower limb and control of infection as well as novel therapies, which are becoming available to treat nonhealing, "no-option" diabetic ulcers, are discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20483808     DOI: 10.1177/1534734610371600

Source DB:  PubMed          Journal:  Int J Low Extrem Wounds        ISSN: 1534-7346            Impact factor:   2.057


  24 in total

1.  Ciprofloxacin-loaded calcium alginate wafers prepared by freeze-drying technique for potential healing of chronic diabetic foot ulcers.

Authors:  Asif Ahmed; Giulia Getti; Joshua Boateng
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

2.  Combined effects of low-level laser therapy and human bone marrow mesenchymal stem cell conditioned medium on viability of human dermal fibroblasts cultured in a high-glucose medium.

Authors:  Farzane Hendudari; Abbas Piryaei; Seyedeh-Nafiseh Hassani; Hasan Darbandi; Mohammad Bayat
Journal:  Lasers Med Sci       Date:  2016-03-16       Impact factor: 3.161

Review 3.  Bone, sweet bone--osteoporotic fractures in diabetes mellitus.

Authors:  Christine Hamann; Stephan Kirschner; Klaus-Peter Günther; Lorenz C Hofbauer
Journal:  Nat Rev Endocrinol       Date:  2012-01-17       Impact factor: 43.330

Review 4.  Literature review on the management of diabetic foot ulcer.

Authors:  Leila Yazdanpanah; Morteza Nasiri; Sara Adarvishi
Journal:  World J Diabetes       Date:  2015-02-15

5.  [Resources and models for diabetic foot care in Catalonia (Spain): a descriptive study on areas of improvement].

Authors:  Jerónimo Jurado-Campos; Edurne Zabaleta-Del-Olmo; Carme Farré-Grau; Josep Barceló-Prats; Dolors Juvinyà-Canal
Journal:  Aten Primaria       Date:  2011-10-28       Impact factor: 1.137

Review 6.  Redox Signaling in Diabetic Wound Healing Regulates Extracellular Matrix Deposition.

Authors:  Britta Kunkemoeller; Themis R Kyriakides
Journal:  Antioxid Redox Signal       Date:  2017-08-10       Impact factor: 8.401

7.  The contralateral extremity has also benefit from the locally administered bone marrow-derived mononuclear cells and cord blood serum in diabetic ischemic wound healing.

Authors:  A Tulga Ulus; Ferda Alpaslan Pınarli; Devrim Sonmez; Ahmet Yesilyurt; Tuncay Delibasi
Journal:  Stem Cell Rev Rep       Date:  2014-02       Impact factor: 5.739

8.  1α,25-Dihydroxyvitamin D3 promotes bone formation by promoting nuclear exclusion of the FoxO1 transcription factor in diabetic mice.

Authors:  Yi Xiong; Yixin Zhang; Na Xin; Ying Yuan; Qin Zhang; Ping Gong; Yingying Wu
Journal:  J Biol Chem       Date:  2017-10-17       Impact factor: 5.157

9.  Comparison of five systems of classification of diabetic foot ulcers and predictive factors for amputation.

Authors:  Byung-Joon Jeon; Hwan Jun Choi; Jin Seok Kang; Min Sung Tak; Eun Soo Park
Journal:  Int Wound J       Date:  2016-10-10       Impact factor: 3.315

10.  [Fingertip necroses of unknown origin].

Authors:  F Butsch; B M Rudolph; R Schopf
Journal:  Hautarzt       Date:  2013-02       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.